Passa al contenuto
Merck
  • Induction of the fatty acid 2-hydroxylase (FA2H) gene by Δ(9)-tetrahydrocannabinol in human breast cancer cells.

Induction of the fatty acid 2-hydroxylase (FA2H) gene by Δ(9)-tetrahydrocannabinol in human breast cancer cells.

The Journal of toxicological sciences (2013-03-29)
Shuso Takeda, Mari Harada, Shengzhong Su, Shunsuke Okajima, Hiroko Miyoshi, Kazutaka Yoshida, Hajime Nishimura, Yoshiko Okamoto, Toshiaki Amamoto, Kazuhito Watanabe, Curtis J Omiecinski, Hironori Aramaki
ABSTRACT

To investigate gene(s) being regulated by ∆(9)-tetrahydrocannabinol (∆(9)-THC), we performed DNA microarray analysis of human breast cancer MDA-MB-231 cells, which are poorly differentiated breast cancer cells, treated with ∆(9)-THC for 48 hr at an IC50 concentration of approximately 25 µM. Among the highly up-regulated genes (> 10-fold) observed, fatty acid 2-hydroxylase (FA2H) was significantly induced (17.8-fold). Although the physiological role of FA2H has not yet been fully understood, FA2H has been shown to modulate cell differentiation. The results of Oil Red O staining after ∆(9)-THC exposure showed the distribution of lipid droplets (a sign of the differentiated phenotype) in cells. Taken together, the results obtained here indicate that FA2H is a novel ∆(9)-THC-regulated gene, and that ∆(9)-THC induces differentiation signal(s) in poorly differentiated MDA-MB-231 cells.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Supelco
(−)-trans-Δ9-THC, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®